BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22293355)

  • 1. Pharmacokinetic and pharmacodynamic evaluation of the anti-cataract effect of eye drops containing disulfiram and low-substituted methylcellulose using ICR/f rats as a hereditary cataract model.
    Nagai N; Ito Y; Takeuchi N
    Biol Pharm Bull; 2012; 35(2):239-45. PubMed ID: 22293355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delay in ICR/f rat lens opacification by the instillation of eye drops containing disulfiram and hydroxypropyl-beta-cyclodextrin inclusion complex.
    Nagai N; Takeda M; Ito Y; Takeuchi N; Kamei A
    Biol Pharm Bull; 2007 Aug; 30(8):1529-34. PubMed ID: 17666815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Eye Drops Containing Disulfiram and Low-Substituted Methylcellulose in Reducing Intraocular Pressure in Rabbit Models.
    Nagai N; Yoshioka C; Mano Y; Ito Y; Okamoto N; Shimomura Y
    Curr Eye Res; 2015; 40(10):990-1000. PubMed ID: 25330366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of disulfiram eye drops on lipid peroxide formation via excessive nitric oxide in lenses of hereditary cataract ICR/f rats.
    Nagai N; Ito Y; Takeuchi N
    Biol Pharm Bull; 2008 May; 31(5):981-5. PubMed ID: 18451530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lipid composition on the transcorneal penetration of liposomes containing disulfiram, a potential anti-cataract agent, in the rabbit.
    Ito Y; Cai H; Koizumi Y; Hori R; Terao M; Kimura T; Takagi S; Tomohiro M
    Biol Pharm Bull; 2000 Mar; 23(3):327-33. PubMed ID: 10726888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in intraocular pressure by the instillation of eye drops containing disulfiram included with 2-hydroxypropyl-β-cyclodextrin in rabbit.
    Ito Y; Nagai N; Shimomura Y
    Biol Pharm Bull; 2010; 33(9):1574-8. PubMed ID: 20823577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure.
    Nagai N; Yoshioka C; Mano Y; Tnabe W; Ito Y; Okamoto N; Shimomura Y
    Exp Eye Res; 2015 Mar; 132():115-23. PubMed ID: 25633346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between prevention of cataract development by disulfiram and fates of selenium in selenite-treated rats.
    Ito Y; Cai H; Koizumi Y; Nakao M; Terao M
    Curr Eye Res; 1999 Apr; 18(4):292-9. PubMed ID: 10372989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octa-arginine modified lipid emulsions as a potential ocular delivery system for disulfiram: A study of the corneal permeation, transcorneal mechanism and anti-cataract effect.
    Liu C; Lan Q; He W; Nie C; Zhang C; Xu T; Jiang T; Wang S
    Colloids Surf B Biointerfaces; 2017 Dec; 160():305-314. PubMed ID: 28950195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Ophthalmic Formulation of Disulfiram Nanoparticles Prolongs Drug Residence Time in Lens.
    Nagai N; Mano Y; Ito Y
    Biol Pharm Bull; 2016; 39(11):1881-1887. PubMed ID: 27803460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of aldehyde dehydrogenase 3A1 to disulfiram penetration through monolayers consisting of cultured human corneal epithelial cells.
    Nagai N; Inomata M; Ito Y
    Biol Pharm Bull; 2008 Jul; 31(7):1444-8. PubMed ID: 18591790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitive effects of enhanced lipid peroxidation on Ca(2+)-ATPase in lenses of hereditary cataract ICR/f rats.
    Nagai N; Ito Y; Takeuchi N
    Toxicology; 2008 May; 247(2-3):139-44. PubMed ID: 18403084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere Attrition in Human Lens Epithelial Cells Associated with Oxidative Stress Provide a New Therapeutic Target for the Treatment, Dissolving and Prevention of Cataract with N-Acetylcarnosine Lubricant Eye Drops. Kinetic, Pharmacological and Activity-Dependent Separation of Therapeutic Targeting: Transcorneal Penetration and Delivery of L-Carnosine in the Aqueous Humor and Hormone-Like Hypothalamic Antiaging Effects of the Instilled Ophthalmic Drug Through a Safe Eye Medication Technique.
    Babizhayev MA; Yegorov YE
    Recent Pat Drug Deliv Formul; 2016; 10(2):82-129. PubMed ID: 26084629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ocular drug delivery system containing zinc diethyldithiocarbamate and HPbetaCD inclusion complex--corneal permeability, anti-cataract effects and mechanism studies.
    Wang S; Li D; Ito Y; Liu X; Zhang J; Wu C
    J Pharm Pharmacol; 2004 Oct; 56(10):1251-7. PubMed ID: 15482639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disulfiram inhibites the development of cataract in OXYS rats].
    Fursova AZ; Rumyantseva YV; Kolosova NG; Kedik SA; Panov AV; Tyukova VC
    Adv Gerontol; 2016; 29(1):68-73. PubMed ID: 28423248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delay of cataract development in hereditary cataract UPL rats by disulfiram and aminoguanidine.
    Nabekura T; Koizumi Y; Nakao M; Tomohiro M; Inomata M; Ito Y
    Exp Eye Res; 2003 Feb; 76(2):169-74. PubMed ID: 12565804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: pharmacokinetic assay of Can-C N-acetylcarnosine prodrug lubricant eye drops for cataract prevention.
    Babizhayev MA
    Drugs R D; 2005; 6(6):345-69. PubMed ID: 16274259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive hydrogen peroxide enhances the attachment of amyloid β1-42 in the lens epithelium of UPL rats, a hereditary model for cataracts.
    Nagai N; Ito Y
    Toxicology; 2014 Jan; 315():55-64. PubMed ID: 23941810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
    Nagai N; Ito Y; Okamoto N; Shimomura Y
    Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.